NCT05948540 - Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

September 30, 2026

Conditions

Post Traumatic Stress Disorder

Interventions

DRUG

Intervention C Daridorexant

Daridorexant will be administered 50 mg once daily at least 2 hours after the last meal and within 30 minutes of going to bed.

DRUG

Intervention C Placebo

A matching placebo will be administered at 50 mg daily in the same regimen as the intervention.

Trial Locations (10)

14221

RECRUITING

Upstate Clinical Research Associates, LLC, Williamsville

30318

RECRUITING

Advanced Discovery Research, Atlanta

33032

RECRUITING

Homestead Associates in Research, Inc., Miami

41075

RECRUITING

Cincinnati Veteran's Affairs Medical Center, Fort Thomas

78236

RECRUITING

Wilford Hall Ambulatory Surgical Center (WHASC), San Antonio

96859

RECRUITING

Tripler Army Medical Center (TAMC), Tripler AMC

98433

RECRUITING

Madigan Army Medical Center, Joint Base Lewis McChord

85012-1839

RECRUITING

Phoenix VA Healthcare System, Phoenix

20889-5632

RECRUITING

Walter Reed National Military Medical Center (WRNMC), Bethesda

22060-5285

RECRUITING

Alexander T. Augusta Military Medical Center (ATAMMC):, Fort Belvoir